Waverley Pharma (TSXV:WAVE) YoY Rev. per Sh. Growth : -66.67% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Waverley Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -66.67%.

Waverley Pharma's Revenue per Share for the three months ended in Dec. 2023 was C$0.00.

Waverley Pharma YoY Rev. per Sh. Growth Historical Data

The historical data trend for Waverley Pharma's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma YoY Rev. per Sh. Growth Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

425.00

19.05

28.00

-28.13

-65.22

Waverley Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-66.67	-66.67	-62.50	-66.67	-66.67

Waverley Pharma YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Waverley Pharma's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.008	-	0.023)	/	\| 0.023 \|
=	-65.22 %

Waverley Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=	(Revenue per Share (Q: Dec. 2023 )	-	Revenue per Share (Q: Dec. 2022 ))	/	\| Revenue per Share (Q: Dec. 2022 )) \|
=	(0.001	-	0.003)	/	\| 0.003 \|
=	-66.67 %

Waverley Pharma YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Executives

Albert David Friesen

10% Security Holder, Director, Senior Officer